About: http://webisa.webdatacommons.org/103173391

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	HBI is currently engaged in the development of a product pipeline of recombinant subunit vaccines, including vaccine candidates for tick-borne flavivirus, malaria, Crimean-Congo hemorrhagic fever, and other infectious agents.
http://www.w3.org/ns/prov#wasQuotedFrom	biospace.com